Clinical Trial

Singapore Cohort of Patients with Advanced Heart Failure

Study acronym: SCOPAH
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 5, 2025 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Chronic Heart Failure (CHF) is one of the leading causes of death in Singapore. Although it is well established that CHF patients in Singapore are less likely to be referred to palliative care services than cancer patients, little data is available on end-of-life (EOL) experience of advanced CHF patients in Singapore, including the inter-relationships between patient decision-making, quality of life trajectories, and health and cost consequences.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2017-03-20; most recent amendment 2025-02-03.
Status change: Recruiting → Active, Not Recruiting 2020-07-21
Status change: Not Yet Recruiting → Recruiting 2017-07-24
Trial Details
NCT Number NCT03089034
Lead Sponsor Duke-NUS Graduate Medical School
Collaborators: Singapore General Hospital, National Heart Centre Singapore
Conditions Chronic Heart Failure
Enrollment 300 participants
Start Date 2017-07-24
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-05